Schedule 13G ownership disclosure

APTEVO THERAPEUTICS INC

Common Stock · CUSIP: 03835L504

Event date: 2025-08-14

Filing-level shares
164,300.00
Percent of class
4.99%
  • L1 Capital Global Opportunities Master Fund, Ltd.

    Shares: 164,300.00 · Class: 4.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001079973-25-001313
Form type
SCHEDULE 13G/A
Filer
Aptevo Therapeutics Inc.
CIK
CIK 1671584
Filed
Aug 14, 2025
Reporting period
Aug 14, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub